Sana Biotechnology Inc vs Sibanye Stillwater Ltd — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Sibanye Stillwater Ltd trades at $8.59 (market cap $5.66B). The key difference: Sibanye Stillwater Ltd is far larger — about 6.5× Sana Biotechnology Inc's market cap, and Sibanye Stillwater Ltd pays a 3.89% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SBSW | |
|---|---|---|
Market Cap | $873.84M | $5.66B |
Sector | Health | Basic Materials |
52-Week High | $5.92 | $21.12 |
52-Week Low | $2.68 | $7.27 |
Enterprise Value | $848.03M | $7.28B |
Dividend Yield | — | 3.89% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →